AMERICAN HEALTHCARE REIT, INC.

AHR

CIK 0001632970 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$604M
↑+11.3% +$61Mvs FY2024 (Q4)
Operating Income
$112M
↑+12.6% +$12Mvs FY2024 (Q4)
Net Income
$8M
↓-88.5% -$61Mvs FY2024 (Q4)
Gross Profit
$124M
↑+10.4% +$12Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
31/100
  • Profitability
    49ROIC 14.9% (10% = solid, 20%+ = moat)
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    20Asset Turnover 0.46x (1.0+ = capital-efficient)
  • Growth
    54Revenue YoY +11.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    64Op Margin 18.5% · trend +0.8pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project AHR's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 25.8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$58.86
Total enterprise IV
$9.82B
Diluted shares
0.17B
Terminal PV
$7.63B (78% of total)
Year-5 FCF
$899M
YearProjected FCFDiscounted PV
+1$368M$335M
+2$460M$380M
+3$575M$432M
+4$719M$491M
+5$899M$558M
Terminal$12.28B$7.63B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Dividends paid (TTM)
$164M
cash returned to holders
Stock buybacks (TTM)
$0
share count reduction
Stock-based comp (TTM)
$15M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$5.43B
everything owned
Total liabilities
$2.07B
everything owed
Stockholders' equity
$3.32B
shareholder claim

Recent performance · 44 quarters

Revenue↑+11.3% +$61M
$604M
Net Income
$11M
Free Cash Flow↓-7.3% -$4M
$55M
Operating Margin↑+0.2pts
18.5%

Drill down